CoChat

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer

Open access
Patten, Darren K., Corleone, Giacomo, Győrffy, Balázs, Perone, Ylenia, Slaven, Neil, Barozzi, Iros, Erdős, Edina, Saiakhova, Alina, Goddard, Kate, Vingiani, Andrea, Shousha, Sami, Pongor, Lőrinc Sándor, Hadjiminas, Dimitri J., Schiavon, Gaia, Barry, Peter, Palmieri, Carlo, Coombes, Raul C., Scacheri, Peter, Pruneri, Giancarlo, Magnani, Luca · 2018 · Nature Medicine
Cited by 131

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

The degree of intrinsic and interpatient phenotypic heterogeneity and its role in tumor evolution is poorly understood. Phenotypic drifts can be transmitted via inheritable transcriptional programs. Cell-type specific transcription is maintained through the activation of epigenetically defined regulatory regions including promoters and enhancers. Here we have annotated the epigenome of 47 primary and metastatic estrogen-receptor (ERα)-positive breast cancer clinical specimens and inferred phenotypic heterogeneity from the regulatory landscape, identifying key regulatory elements commonly shared across patients. Shared regions contain a unique set of regulatory information including the motif for transcription factor YY1. We identify YY1 as a critical determinant of ERα transcriptional activity promoting tumor growth in most luminal patients. YY1 also contributes to the expression of genes mediating resistance to endocrine treatment. Finally, we used H3K27ac levels at active enhancer elements as a surrogate of intra-tumor phenotypic heterogeneity to track the expansion and contraction of phenotypic subpopulations throughout breast cancer progression. By tracking the clonality of SLC9A3R1-positive cells, a bona fide YY1-ERα-regulated gene, we show that endocrine therapies select for phenotypic clones under-represented at diagnosis. Collectively, our data show that epigenetic mechanisms significantly contribute to phenotypic heterogeneity and evolution in systemically treated breast cancer patients. Topographic analysis of the active regulatory landscape in estrogen receptor-positive breast cancer uncovers a role for transcription factor YY1 in modulating phenotypic heterogeneity during tumor evolution and endocrine resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0091-x

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 131

Metadata

Authors
Patten, D. K., Corleone, G., Győrffy, B., Perone, Y., Slaven, N., Barozzi, I., Erdős, E., Saiakhova, A., Goddard, K., Vingiani, A., Shousha, S., Pongor, L. S., Hadjiminas, D. J., Schiavon, G., Barry, P., Palmieri, C., Coombes, R. C., Scacheri, P., Pruneri, G., & Magnani, L.
Venue
Nature Medicine
Published
2018-07-23
Volume
24
Issue
9
Pages
1469-1480
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2883066454
Cited by
131
References
24
FWCI
5.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer. https://app.cochat.ai/papers/10.1038/s41591-018-0091-x
The paper
Patten, D. K., Corleone, G., Győrffy, B., Perone, Y., Slaven, N., Barozzi, I., Erdős, E., Saiakhova, A., Goddard, K., Vingiani, A., Shousha, S., Pongor, L. S., Hadjiminas, D. J., Schiavon, G., Barry, P., Palmieri, C., Coombes, R. C., Scacheri, P., Pruneri, G., & Magnani, L. (2018). Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer. Nature Medicine. https://doi.org/10.1038/s41591-018-0091-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.